Salarius Pharmaceuticals, Inc. Insider Trading for March 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Salarius Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Salarius Pharmaceuticals, Inc. for March 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 25 2016 | FLKS | Flex Pharma, Inc. | Westphal Christoph H | President and CEO | Buy | P | 10.55 | 24,207 | 255,384 | 2,960,518 | 2.9 M to 3 M (+0.82 %) |
| Mar 25 2016 | FLKS | Flex Pharma, Inc. | Westphal Christoph H | President and CEO | Buy | P | 11.55 | 25,356 | 292,862 | 2,936,311 | 2.9 M to 2.9 M (+0.87 %) |
| Mar 23 2016 | FLKS | Flex Pharma, Inc. | Westphal Christoph H | President and CEO | Buy | P | 11.78 | 23,951 | 282,143 | 2,910,955 | 2.9 M to 2.9 M (+0.83 %) |
| Mar 23 2016 | FLKS | Flex Pharma, Inc. | Westphal Christoph H | President and CEO | Buy | P | 11.70 | 24,107 | 282,052 | 2,887,004 | 2.9 M to 2.9 M (+0.84 %) |
| Mar 21 2016 | FLKS | Flex Pharma, Inc. | Westphal Christoph H | President and CEO | Buy | P | 11.06 | 18,437 | 203,913 | 2,862,897 | 2.8 M to 2.9 M (+0.65 %) |
| Mar 21 2016 | FLKS | Flex Pharma, Inc. | Westphal Christoph H | President and CEO | Buy | P | 10.94 | 19,137 | 209,359 | 2,844,460 | 2.8 M to 2.8 M (+0.68 %) |
| Mar 17 2016 | FLKS | Flex Pharma, Inc. | Westphal Christoph H | President and CEO | Buy | P | 10.85 | 19,142 | 207,691 | 2,825,323 | 2.8 M to 2.8 M (+0.68 %) |
| Mar 17 2016 | FLKS | Flex Pharma, Inc. | Westphal Christoph H | President and CEO | Buy | P | 9.62 | 19,237 | 185,060 | 2,806,181 | 2.8 M to 2.8 M (+0.69 %) |
| Mar 16 2016 | FLKS | Flex Pharma, Inc. | Stacy Michelle | Director | Buy | P | 9.63 | 2,585 | 24,894 | 2,585 | 0 to 2.6 K |
| Mar 15 2016 | FLKS | Flex Pharma, Inc. | Longwood Fund II, L.P. | 10% Owner | Buy | P | 7.00 | 89,680 | 627,760 | 2,786,944 | 2.7 M to 2.8 M (+3.32 %) |
| Mar 15 2016 | FLKS | Flex Pharma, Inc. | Westphal Christoph H | President and CEO | Buy | P | 7.00 | 89,680 | 627,760 | 2,786,944 | 2.7 M to 2.8 M (+3.32 %) |
| Mar 15 2016 | FLKS | Flex Pharma, Inc. | Wessel Thomas | Chief Medical Offic ... | Buy | P | 9.13 | 8,000 | 73,040 | 57,064 | 49.1 K to 57.1 K (+16.31 %) |
| Mar 15 2016 | FLKS | Flex Pharma, Inc. | Wessel Thomas | Chief Medical Offic ... | Buy | P | 7.15 | 12,000 | 85,800 | 49,064 | 37.1 K to 49.1 K (+32.38 %) |
| Mar 15 2016 | FLKS | Flex Pharma, Inc. | MacKinnon Roderick | Director | Buy | P | 7.03 | 10,000 | 70,261 | 431,277 | 421.3 K to 431.3 K (+2.37 %) |
| Mar 08 2016 | FLKS | Flex Pharma, Inc. | Stacy Michelle | Director | Option Exercise | A | 7.20 | 20,000 | 144,000 | 20,000 |